Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
All right. Good afternoon. I'm Eric Joseph, senior biotech analyst with JPMorgan. Our next presenting company this afternoon is Rocket Pharma. And to bring us to the story, it is my pleasure to welcome CEO, Gaurav Shah.
After their presentation, there is a Q&A session. Just wait for the microphone. If you have questions, we'll get it over to you. (Conference Instructions) With that, Gaurav.
Thank you, Eric. Thank you, JPMorgan, for having us. It's always great to be here. And San Francisco is ever-changing and never changing at the same time, so it's good to experience together.
So the key message for today is that a onetime therapy that potentially cures a fatal and devastating disease of childhood because it addresses the disease at the most fundamental level possible, the DNA. This is such a profound change in the way we've thought about medicine in the history of our species, and it could change the future of our species as well. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
